Market Dashboard
Optimystix Entertainment Logo

Optimystix Entertainment

Listed
SMEBook building Issue
Issue Price
₹166 to ₹175
Face Value
₹10 Per Equity Share
Issue Size
₹108.50 Cr.
Listing On
NSE SME
Live

Allotment Available

Check your individual allotment on the official registrar portal.

Check Allotment

Grey Market

₹5
+2.86% Est. Listing Premium
Est. Listing Price₹180
Updated: 14 Aug 2026, 11:56

About Optimystix Entertainment IPO

Incorporated in 2000, Optimystix Entertainment India Limited is a content production company that creates television shows, films, and digital content. It has produced over 150 TV shows and more than 7,500 hours of original programming for leading broadcasters.

Financial Health

Period EndedRevenueAssetsPAT
2024₹55.88₹105.81₹6.69
2025₹125.07₹138.93₹17.24
2026₹135.89₹166.80₹24.04

Live Subscriptions

Updated: 11 Aug 2026, 07:37Tracking
Categoryday 1day 2day 3
nii0.77x0.21x0.32x
retail0.55x0.87x1.12x
qib1.02x1.02x1.02x
Total0.73x0.77x0.92x

Frequently Asked Questions

The public subscription window officially opens on 07 August 2026 and concludes at 5:00 PM IST on 11 August 2026.
As of the latest market information, the GMP is ₹5, indicating a 2.86% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹166 to ₹175. Retail investors must bid for at least 1,600 shares, requiring a block investment of ₹2,80,000.
The allotment has been detected as available in the Maashitla Securities Pvt. Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 14 August 2026.
The registrar for this IPO is Maashitla Securities Pvt. Ltd..
The issue size for Optimystix Entertainment is ₹108.50 Cr..
The current status of the Optimystix Entertainment IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.